Biotechnology Companies Making Major Announcements - Seite 3

PTC Therapeutics, Inc. (NASDAQ: PTCT)

Market Cap: $1.407B, current share price: $30.33 

PTCT plans to host a webcast conference call to report it's first quarter financial results and provide a business update on May 9th, 2018 at 4:30 p.m. (ET).  The company also is going to be participating in an upcoming Investor Conference, the Bank of America Merrill Lynch 2018 Health Care Conference, on Tuesday, May 15th.  Today the company's security finished daily trading up nearly 4%, and is quickly approaching the company's 52 week high.  

Akers Biosciences, Inc. (NASDAQ: AKER)

 Market Cap: $54.4M, current share price: $0.53 

AKER develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics. The Company recently announced the engagement of two leading Independent Sales Representative (ISR) organizations to increase US sales and marketing capabilities for the Company's rapid test for heparin-induced thrombocytopenia (HIT). Investors should keep close watch on AKER to see if the added sales capabilities can result in a share price increase to avoid a potential reverse stock split.

Content Provided By: Microcap Speculators

For Full Legal Disclaimer Click Here.

DISCLAIMER: Microcapspeculators.com (MS) is the source of the content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. FN Media Group (FNM,) and its online brand FinancialNewsMedia.com, is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated with MS or any company mentioned herein. The commentary, views and opinions expressed in this release by MS are solely those of MS and are not shared by and do not reflect in any manner the views or opinions of FNM. Readers of this Article and content agree that they cannot and will not seek to hold liable MS and FNM for any investment decisions by their readers or subscribers. MS and FNM and their respective affiliated companies are a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks included herein by MS. FNM was not compensated by any public company mentioned herein to disseminate this press release on behalf of MS.